Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Ovarian Neoplasms 13Endometrial Neoplasms 4Carcinoma, Ovarian Epithelial 4Breast Neoplasms 4Neoplasms 3Uterine Neoplasms 2Triple Negative Breast Neoplasms 2Small Cell Lung Carcinoma 2Recurrence 2Prostatic Neoplasms 2Lung Neoplasms 2Esophageal Neoplasms 2Carcinoma, Renal Cell 2Uterine Cervical Neoplasms 1Urogenital Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Ovarian Diseases 1Neoplasms, Glandular and Epithelial 1Neoplasms by Site 1Neoplasms by Histologic Type 1Melanoma 1Laryngeal Neoplasms 1Kenny-Caffey syndrome, Type 1 1Hyperglycemia 1High Grade Serous Ovarian Cancer 1Head and Neck Neoplasms 1Genital Neoplasms, Female 1Genital Diseases, Female 1Fallopian Tube Neoplasms 1

Interventions

Fluorouracil 3durvalumab 2ceralasertib 2Oxaliplatin 2Leucovorin 2Gemcitabine 21-phenyl-3,3-dimethyltriazene 2pembrolizumab 1olaparib 1Stents 1Relaxation Therapy 1Radiotherapy 1Radiofrequency Ablation 1Photochemotherapy 1Nutritional Status 1Long-Term Synaptic Depression 1Lasers 1Irinotecan 1Filgrastim 1Exercise 1Enteral Nutrition 1Cyclooxygenase 2 Inhibitors 1Cisplatin 1Celecoxib 1CGX1321 1Biopsy, Fine-Needle 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Bile Duct Neoplasms × olaparib × Clear all
NCT04298021 2024-04-19

DDR-Umbrella Study of DDR Targeting Agents in Advanced Biliary Tract Cancer

Seoul National University Hospital

Phase 2 Unknown
74 enrolled
Gastrointestinal

Bile Duct Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡